Gene · 406909
Papers2,249
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,249
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Retraction Notice to "Bone marrow stromal cells-derived exosomes reduce neurological damage in traumatic brain injury through the miR-124-3p/p38 MAPK/GLT-1 axis" [Experimental Neurology 365 (2023) 114408]. | Exp Neurol | 2026 | 41945041 | PubTator, text mining | PubMed |
| Identification of key genes associated with butyrate metabolism in keratoconus through Mendelian randomization and transcriptomic analysis. | Exp Eye Res | 2026 | 41935768 | PubTator, text mining | PubMed |
| MiR-124-3p Suppresses Glioma Cells Progression by Targeting STAT3/NAMPT and Inhibiting AKT/ERK Signaling. | Curr Cancer Drug Targets | 2026 | 41935350 | PubTator, text mining | PubMed |
| Evaluation of miRNA-133a-3p and miRNA-124-3p expression in atherosclerosis using real-time PCR and immunohistochemical methods. | Indian J Med Res | 2026 | 41934428 | PubTator, text mining | PubMed |
| Obesity, Nutrition and the Multiple Sclerosis Risk in Adolescents. | Brain Sci | 2026 | 41892626 | PubTator, text mining | PubMed |
| Multifaceted roles of miR‑124 in cancer: Molecular mechanisms and clinical prospects (Review). | Int J Oncol | 2026 | 41891957 | PubTator, text mining | PubMed |
| Preservation of miR-9-5p and miR-124-3p in ALS-resistant oculomotor neurons contrasts with their downregulation in vulnerable spinal motor neurons, irrespective of TDP-43 pathology. | Acta Neuropathol | 2026 | 41888437 | PubTator, text mining | PubMed |
| MicroRNA combinations function as synergistic network regulators of neuroblastoma differentiation. | bioRxiv | 2026 | 41867718 | PubTator, text mining | PubMed |
| Growth Hormone Deficiency and Subsequent Replacement Therapy Trigger Differential Expression of Specific MicroRNAs in Males and Females: Not Just a Matter of Height. | Horm Res Paediatr | 2026 | 41861067 | PubTator, text mining | PubMed |
| Role of liver X receptors in the pathogenesis and treatment of chronic liver disease (Review). | Mol Med Rep | 2026 | 41860051 | PubTator, text mining | PubMed |
| Integrated transcriptomic, protein, and MicroRNA profiling reveals a conserved pyroptosis-related molecular signature across breast cancer subtypes. | Front Mol Biosci | 2026 | 41858736 | PubTator, text mining | PubMed |
| Profiling miRNA in Systemic Lupus Erythematosus Patients Adhering to a Mediterranean Diet: An Interventional Pilot Study. | J Clin Med | 2026 | 41827493 | PubTator, text mining | PubMed |
| Circular RNAs: Key Regulators of Tumor Metabolic Reprogramming and Clinical Translation. | Oncol Res | 2026 | 41799520 | PubTator, text mining | PubMed |
| The role of miRNAs in the development of brain metastases originating from lung adenocarcinoma. | Front Genet | 2026 | 41799343 | PubTator, text mining | PubMed |
| Exosome-delivered bioactive molecules regulate macrophage polarization in atherosclerosis and myocardial infarction: mechanisms and therapeutic potential. | Front Cardiovasc Med | 2026 | 41798608 | PubTator, text mining | PubMed |
| Comprehensive Analysis Reveals Potential Molecular Targets in Juvenile Dermatomyositis. | Biochem Res Int | 2026 | 41797822 | PubTator, text mining | PubMed |
| Exploration of the co-regulatory mechanism of calorie restriction and endurance exercise on elderly skeletal muscle and its potential intervention targets. | Exp Gerontol | 2026 | 41794155 | PubTator, text mining | PubMed |
| Epigenetic mechanisms and steroid-resistant nephrotic syndrome: The future potential for SRNS diagnosis. | iScience | 2026 | 41782821 | PubTator, text mining | PubMed |
| Role of Stem Cells and Stem Cell Markers in Oral Potentially Malignant Disorders and Malignant Transformation: A Systematic Review. | Stem Cells Int | 2026 | 41778103 | PubTator, text mining | PubMed |
| Exosomes as Pivotal Mediators of Tumor-Immune Communication: Implications for Immunotherapy and Liquid Biopsy. | Int J Nanomedicine | 2026 | 41773242 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406909/papers?page=2